Sientra Inc (SIENQ)
OTCMKTS: SIENQ · Delayed Price · USD
0.0615
0.00 (0.00%)
May 2, 2024, 12:00 AM EDT - Market open
Sientra Revenue
Sientra had revenue of $90.30M in the twelve months ending September 30, 2023, with 2.46% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $19.54M, a -13.41% decrease year-over-year. In the year 2022, Sientra had annual revenue of $90.55M with 12.23% growth.
Revenue (ttm)
$90.30M
Revenue Growth
+2.46%
P/S Ratio
0.01
Revenue / Employee
$297,036
Employees
304
Market Cap
694.38K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 90.55M | 9.87M | 12.23% |
Dec 31, 2021 | 80.68M | 25.69M | 46.70% |
Dec 31, 2020 | 55.00M | 8.63M | 18.62% |
Dec 31, 2019 | 46.36M | -21.76M | -31.95% |
Dec 31, 2018 | 68.13M | 31.58M | 86.43% |
Dec 31, 2017 | 36.54M | 15.81M | 76.24% |
Dec 31, 2016 | 20.73M | -17.37M | -45.59% |
Dec 31, 2015 | 38.11M | -6.63M | -14.81% |
Dec 31, 2014 | 44.73M | 9.56M | 27.19% |
Dec 31, 2013 | 35.17M | 24.72M | 236.66% |
Dec 31, 2012 | 10.45M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |